Causes and Risk Factors for Multiple Sclerosis: What We Know

Multiple sclerosis (MS) is a condition that affects millions of people worldwide, yet its exact cause remains one of neuroscience’s most studied puzzles. Research consistently points to a complex interplay of immune dysfunction, genetics, and environmental exposure – not a single trigger. Understanding these risk factors matters not just clinically, but for anyone involved in education, caregiving, or disability support. Here is a clear, evidence-based breakdown of what we currently know.

The autoimmune basis of MS 🔗

At its core, MS is classified as an autoimmune disease. This means the body’s own immune system mistakenly identifies healthy tissue as a threat and attacks it. In MS, that target is the myelin sheath – the protective, fatty coating surrounding nerve fibers in the central nervous system (CNS), which includes the brain, spinal cord, and optic nerve.

When myelin is damaged, nerve signals slow down or fail to transmit altogether. Over time, the affected areas develop scar tissue, which is where the name “sclerosis” (meaning scarring) comes from. According to Banner Health, two key immune cells drive this process: T cells, which enter the CNS and trigger inflammation, and B cells, which produce antibodies that further damage myelin and nerve tissue. The result is disrupted communication between the brain and the rest of the body, producing MS’s wide range of neurological symptoms.

What remains unknown is why the immune system turns on the CNS in the first place. Scientists believe it results from a combination of genetic vulnerability and environmental triggers – but the precise sequence of events has not yet been fully established.

Key demographic and genetic risk factors 🔗

MS does not discriminate entirely – it can affect anyone – but certain groups face a significantly higher risk. Understanding these patterns helps identify who may be most vulnerable.

Age and sex 🔗

Brigham and Women’s Hospital notes that most people are diagnosed between the ages of 20 and 40, though MS can appear later in life (after 50) or rarely, in childhood. Sex is one of the strongest demographic predictors: women are approximately three times more likely to develop the relapsing-remitting form of MS than men, though men and women develop the primary progressive form at more comparable rates. The reason for this disparity is not fully understood but is thought to involve hormonal and immune system differences.

Genetics and family history 🔗

MS is not a straightforwardly inherited disease – having a parent with MS does not mean a child will definitely develop it. However, genetics clearly plays a role. About one in five MS patients has a family history of the condition, and those with a parent who has MS face a roughly 2% lifetime risk of developing the disease themselves.

At the molecular level, the most significant genetic signal maps to the HLA (Human Leukocyte Antigen) gene cluster, located on chromosome 6. Research published in PMC identifies the HLA-DRB1*15:01 allele as carrying the strongest genetic risk, associated with approximately a threefold increase in MS susceptibility. These HLA genes regulate how the immune system recognises its own cells – a function that appears to go wrong in MS. Beyond the HLA region, genome-wide association studies have identified more than 200 additional genetic variants that each contribute modest but measurable increases in risk.

Race and ethnicity 🔗

MS is most prevalent among people of Northern European descent. Individuals of African, Asian, or Indigenous descent generally show lower rates, though MS among Black individuals tends to follow a more aggressive course. These differences likely reflect a combination of genetic background, geographic factors, and access to diagnosis.

Environmental and lifestyle influences 🔗

Even among people with genetic susceptibility, MS does not inevitably develop. Environmental and lifestyle factors appear to determine whether that underlying risk is “activated.” Several have been identified with strong or growing evidence.

Geography and sunlight 🔗

MS is notably more common in temperate climates – particularly those further from the equator. Regions such as northern Europe, Canada, New Zealand, and southeastern Australia report higher rates than equatorial countries. The leading explanation links geography to sunlight: less sun exposure means less vitamin D production, and low vitamin D is consistently linked to higher MS risk.

Vitamin D deficiency 🔗

Vitamin D is far more than a bone health supplement – it plays a significant role in modulating immune function. Studies show that vitamin D acts through the vitamin D receptor (VDR) to regulate immune cells, helping maintain a balance between pro-inflammatory and anti-inflammatory responses. When vitamin D levels are insufficient, immune cells may shift towards subtypes that promote inflammation in the CNS. Multiple studies have confirmed a negative correlation between vitamin D levels and MS risk, and research published in Frontiers in Immunology describes EBV infection and low vitamin D as two of the most strongly evidenced environmental risk factors for MS onset – with evidence suggesting they may have an additive effect.

Epstein-Barr virus (EBV) 🔗

Among all identified risk factors, the Epstein-Barr virus (EBV) – the pathogen responsible for infectious mononucleosis – has emerged as the most compelling. An EBV infection has been shown to increase the risk of developing MS by 32 times compared to those never infected. Crucially, EBV infection alone is not enough – the vast majority of the global population carries EBV without ever developing MS. The current leading theory, as reviewed in Frontiers in Immunology, is that EBV may trigger MS through molecular mimicry – a process where the immune system, while fighting the virus, inadvertently generates responses that also attack myelin. The combination of EBV infection with the HLA-DRB1*1501 genetic risk allele is associated with a particularly elevated MS risk, higher than either factor alone.

Smoking 🔗

Cigarette smoking is a well-established modifiable risk factor for MS. A comprehensive review in PMC confirms that smokers carrying HLA MS risk genes face a considerably higher risk than non-smokers with those same genes, suggesting smoking actively interacts with genetic susceptibility rather than simply adding an independent risk. Smoking has also been associated with faster disease progression in those already diagnosed. Even passive exposure in childhood has been flagged as a concern, though the evidence base for this remains limited.

Obesity, especially in adolescence 🔗

Childhood and adolescent obesity is recognised as a risk factor for MS in adulthood. Research suggests that obesity may interact with EBV and HLA risk genes, potentially amplifying neuroinflammatory processes. A pro-inflammatory environment associated with excess adipose tissue during developmentally sensitive periods could contribute to the cascade that eventually triggers MS. This finding has particular relevance given the global rise in childhood obesity rates.

Other autoimmune diseases 🔗

Having one autoimmune disease increases the likelihood of developing another. Conditions such as lupus, rheumatoid arthritis, thyroid disease, type 1 diabetes, and inflammatory bowel disease have all been found to co-occur with MS at higher than expected rates – particularly in women. This overlap is thought to arise from shared genetic pathways, similar immune system vulnerabilities, and comparable environmental exposures across autoimmune conditions.

A multifactorial picture 🔗

What is clear from the evidence is that MS does not have a single cause. It emerges from the intersection of genetic susceptibility, immune dysfunction, and environmental exposure – and no single factor alone is sufficient to trigger the disease. As the Pacific Neuroscience Institute explains, MS is best understood as a condition in which precise genes and environmental factors have yet to be conclusively identified, but the interaction between them is unmistakable. This complexity is both a scientific challenge and a reason for ongoing optimism – because several risk factors, particularly smoking, vitamin D deficiency, and obesity, are modifiable.

For educators, disability specialists, and healthcare professionals, understanding this multifactorial model is essential. It moves the conversation beyond fatalism and opens space for prevention-focused thinking, early identification of at-risk individuals, and more informed support for those living with MS.

What do you think? Given that several MS risk factors – like vitamin D deficiency, smoking, and childhood obesity – are potentially modifiable, how might this knowledge shape how disability educators and support professionals approach health literacy in their practice? And with EBV being so widespread yet only a fraction of those infected ever developing MS, what does that tell us about the limits of a single-factor explanation for complex neurological conditions?

References

1. https://www.houstonmethodist.org/neurology/conditions-treatments/neuromuscular-disorders/conditions/multiple-sclerosis-ms/causes/
2. https://www.bannerhealth.com/services/neurology/diseases/multiple-sclerosis/causes-and-risk-factors
3. https://www.brighamandwomens.org/neurology/multiple-sclerosis-information
4. https://www.rarediseaseadvisor.com/hcp-resource/multiple-sclerosis-risk-factors/
5. https://multiplesclerosisnewstoday.com/risk-factors-for-multiple-sclerosis/
6. https://pmc.ncbi.nlm.nih.gov/articles/PMC4687745/
7. https://pmc.ncbi.nlm.nih.gov/articles/PMC10571821/
8. https://pmc.ncbi.nlm.nih.gov/articles/PMC11701136/
9. https://pmc.ncbi.nlm.nih.gov/articles/PMC10406387/
10. https://pmc.ncbi.nlm.nih.gov/articles/PMC6444694/
11. https://www.pacificneuroscienceinstitute.org/brain-health/conditions-treatment/multiple-sclerosis/